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Chronic exposure to particulate matter air pollution is known to cause inflammation leading to respiratory- and cardiovascular-
related sickness and death. Mexico City Metropolitan Area children exhibit an early brain imbalance in genes involved in oxidative
stress, inflammation, and innate and adaptive immune responses. Early dysregulated neuroinflammation, brain microvascular
damage, production of potent vasoconstrictors, and perturbations in the integrity of the neurovascular unit likely contribute
to progressive neurodegenerative processes. The accumulation of misfolded proteins coincides with the anatomical distribution
observed in the early stages of both Alzheimer’s and Parkinson’s diseases. We contend misfolding of hyperphosphorylated tau
(HP𝜋), alpha-synuclein, and beta-amyloid could represent a compensatory early protective response to the sustained systemic
and brain inflammation. However, we favor the view that the chronic systemic and brain dysregulated inflammation and the
diffuse vascular damage contribute to the establishment of neurodegenerative processes with childhood clinical manifestations.
Friend turns Foe early; therefore, implementation of neuroprotective measures to ameliorate or stop the inflammatory and
neurodegenerative processes is warranted in exposed children. Epidemiological, cognitive, structural, and functional neuroimaging
and mechanistic studies into the association between air pollution exposures and the development of neuroinflammation and
neurodegeneration in children are of pressing importance for public health.
1. Introduction
Air pollution is a significant health problem in megacities
around the world [1–3]. In a scenario where the projected
world population will have a further increase of 2 to 4.5
billion in the first 50 years of this century [4], the issue of
deteriorating environments and their health impact is critical.
The problem of air pollution is not confined to large urban
centers, it also affects small cities and rural areas. Particulate
matter (PM) air pollution is a public health problem affecting
millions of people worldwide.
Recent works have shed new light on the etiology of
Alzheimer’s and Parkinson’s diseases (AD and PD), with a
growing body of evidence that oxidative stress and neuroin-
flammation are at the core of their etiopathogenesis and that
there is a close interplay between environmental factors and
neurodegeneration [5–8]. We also know the most beneficial
neuroprotective effects might only be achieved in the very
early stages of the detrimental processes. As such, a great
effort has beenmade in establishing the associations between
particulate air pollution, neuroinflammation, and neurode-
generation in highly exposed megacity children and young
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adults. The first part of this paper deals briefly with the cur-
rent state of air pollution in Mexico City Metropolitan Area
(MCMA) and with the several areas of investigation in our
laboratory that exemplify how seemingly clinically healthy
children are responding to the sustained exposures to air
pollutants. The second part of the paper turns to a more
troublesome challenge. How do you formulate the neu-
ropathology and gene brain expression findings in clinically
healthy children and young adults and establish the links
with the current mainstream concepts of neurodegeneration.
This principled problem thus addresses the relation between
neuroinflammation, neurodegeneration, and air pollution
exposures with an emphasis on compensatory responses.
Dealing with this problem invites the development of linking
hypotheses between the domains and the need for interven-
tion, issues addressed in the third part of the paper.
2. Air Pollution Background and
Clinical Issues in Metropolitan Mexico
City Clinically Health Children
2.1. Air Pollution in Mexico City Metropolitan Area (MCMA).
Although there is significant air pollution associated with
ozone in MCMA, in this work, we will focus on particulate
matter (PM) broadly defined by the diameter of the aerody-
namic particles and classified into coarse particles (<10𝜇m;
PM
10
), fine particles (<2.5 𝜇m; PM
2.5
), and ultrafine particles
(<100 nm; UFPM). Fine and ultrafine PM are of particular
interest given their capability to reach the brain [9]. The
smaller the particle, the greater its penetration, diffusion, and
deposition into the respiratory tract and its direct transloca-
tion into the brain [9–11].
MCMA, the largest urban center in North America, is
an example of extreme urban growth and environmental
pollution [12]. The metropolitan area of over 2000 square
kilometers is home to over 20 million inhabitants including 8
million children. The energy demand of this population and
over 40000 industries and 4 million vehicles consumes more
than 40 million liters of petroleum fuels per day resulting in
an annual emission of approximately 2.6 tons of pollutants
including coarse and fine particulate matter, gaseous pol-
lutants, polycyclic aromatic hydrocarbons, and lipopolysac-
charides [12]. The MCMA is located in the southwestern
portion of an elevated basin 2240m above sea level that is
surrounded on three sides bymountain ridges at 19∘ N 99∘W.
The high altitude and tropical insolation of the basin facilitate
ozone production all year and contribute to the formation of
secondary PM. Air quality is generally worse in the winter
when thermal inversions are more frequent [13].
Even with the substantial reductions in the concentra-
tions of some criteria pollutants (such as lead, CO, and
SO
2
) achieved during the past fifteen years, MCMA residents
remain exposed to concentrations of airborne pollutants ex-
ceeding current ambient air quality standards for PM and
ozone [14]. High concentrations of PM
2.5
as well as significant
levels of PM
10
associated with lipopolysaccharides (PM-LPS)
have been registered historically in Mexico City’s air, and
marked regional differences in the air pollutants concentra-
tions and composition have been reported within MCMA
[12, 15–19].
Figure 1 shows the trend of 24-hour average PM
10
con-
centrations forMCMA(1995–2011). PM
10
concentrations had
shown a clear reduction up to 2007; however, concentrations
have been slowly back on the rise in the last 5 years. PM
2.5
data from the monitoring network [20] in Figure 2 show the
90th percentile of the 24-hour average concentrations per
year have been above the respective air quality standard of
35 𝜇g/m3. MCMA residents are also exposed to UFPM from
ambient air and workplaces. These nano sized PM include
combustion sources (e.g., diesel exhaust particles, welding
fumes) andmanufactured or engineered nanoparticles (NPs).
It is not widely appreciated that nano-sized materials are also
present in many consumer products to which large segments
of the population are exposed (e.g., toothpastes, cosmetics,
sunscreens, food additives, and laser printer emissions) [21,
22].
In this massive exposure chamber, 8 million children
and teens <18 y are receiving the impact of the involuntary
exposure to the polluted air.
2.2. Detrimental NonCNS Effects in Exposed Children. It is
important to emphasize that PM exposure has been epidemi-
ologically associated to a wide spectrum of cardiovascular,
pulmonary, and CNS effects [10, 11, 23–25]. Exposure to fine
PM over a few hours to weeks can trigger cardiovascular
disease-related mortality and nonfatal events [10]. Longer-
term exposure increases the risk for cardiovascular mortality
to an even greater extent than exposures over a few days [10].
In the cardiovascular literature “credible pathological mech-
anisms have been elucidated that lend biological plausibility
to (detrimental) findings” [10]. Two mechanistic pathways
applied to the cardiovascular and lung effects fit precisely the
detrimental pathways in place in MCMA children [8]. These
pathways include: pulmonary and systemic oxidative stress,
and inflammation and direct effects of PM or its constituents
on the vasculature and/or blood elements after translocation
from the lung [10].
The pediatric studies from our laboratory cited in this
work were performed in Mexico City clinically healthy
children with no known risk factors for pulmonary, cardio-
vascular, and CNS pathology or cognitive deficits. MCMA
children are selected from nonsmoking families and their
results compared to age, gender, and socioeconomic status
(SES) matched children residing in low polluted places. The
detrimental nonCNS effects associated to residency in MC
include the following.
(i) Systemic inflammation with increased concentra-
tions of proinflammatory cytokines, chemokines, and
potent vasoconstrictors (i.e., endothelin-1, ET-1). The
concentrations of inflammatory mediators and ET-
1 correlate positively with cumulative exposures to
PM
2.5
and outdoor exposure hours [26]. Chronic
inflammation involving the upper and lower respi-
ratory tracts has been identified as a link between
air pollution and brain damage [26–33]. Continuous
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expression of inflammatory mediators capable of
reaching the CNS promotes the formation of reac-
tive oxygen species (ROS) [8]. Activation of innate
immune responses within the brain may follow the
interactions between circulating cytokines and the
constitutively expressed cytokine receptors of brain
endothelial cells. Such responses may, in turn, be
followed by activation of cells involved in adaptive
immunity [30, 34, 35]. Monocytes are the main
innate immune response mediator cells, producing
and secreting TNF-𝛼, interleukin-6 (IL-6), and IL-
1𝛽, which in turn recruit and increase the activity
of other immune cells [34]. Sustained exposures to
fine and ultrafine PM likely start a chain of events
leading to brain endothelial cell activation, disrup-
tion of the neurovascular unit, altered response of
the innate immune system, neuroinflammation, and
neurodegeneration [8, 30, 34–36].
(ii) Altered immune responses include significant de-
creases in the numbers of natural killer cells and
increased numbers ofmCD14+monocytes andCD8+
cells. The reduction in the number of NK cells goes
along with the low concentrations of interferon
gamma (IFN-𝛾) [28]. MCMA children have mon-
ocytic mCD14 upregulation—a key membranous
receptor involved in lipopolysaccharide (LPS) bind-
ing. The CD14 upregulation represents the early
step in cell activation by LPS involving the innate
immune initial host response to Gram negative bac-
terial infections [37]. MCMA children are historically
exposed to endotoxin associated with PM [17, 28,
32, 38]. The issue is very important because we have
shown there is a significant frontal upregulation of
inflammasome-associated genes in MCMA children
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and young adults [30]. Moreover, particle exposure
has been associated to pathogen sensors and the
signaling by ROS drives inflammasome intracellular
signaling complexes activation [39–41]. Even very low
doses of LPS elicit an augmented response to sub-
sequent endotoxin challenge with a violent immune
response [42]. The priming phenomenon could play
a role in the neuroinflammatory responses observed
in MCMA children [30, 35].
(iii) Pulmonary changes in MCMA children living in
tobacco free homes include bilateral hyperinflation
and increased linear markings observed in chest radi-
ographs and mild bronchial wall thickening, promi-
nent central airways, air trapping and pulmonary
nodules identified by computed tomography scans.
Abnormal lung function tests based on predicted
values are seen in 7.8% of MCMA children. Higher
concentrations of endothelin-1 correlate with eleva-
tions of mean pulmonary artery pressure, average
hours per day spent outdoors, and 7 day cumulative
concentrations of fine PM
2.5
[26, 27].
(iv) Cardiovascular effects include a significant right ven-
tricle upregulation of IL-1𝛽, TNF-𝛼, IL-10, and CD14,
and a left ventricle difference in TNF-𝛼, and IL-10
in South versus North Mexico City residents, a key
point in relation to the marked difference in pollutant
profiles determined by the residenceMCMA location
[43].
2.3. Detrimental CNS Effects in Exposed Children. MCMA
children with no known risk factors for neurological or
cognitive disorders exhibit significant deficits in a combina-
tion of fluid and crystallized cognition tasks versus control
children [29]. Fifty-six percent of MCMA children showed
prefrontal white matter hyperintense (WMH) lesions byMRI
and similar lesions were observed inMCMAdogs (57%) [29].
One control child out of 13 tested exhibited a single white
matter lesion, and this child was an APOE 3/4 carrier [29].
Critical to this paper, MC breed animal facility dogs had
frontal lesions with vascular subcortical pathology associated
with neuroinflammation, enlarged Virchow-Robin spaces,
gliosis, and ultrafine particulate matter deposition [29]. The
dogs MRI findings were the same as the children, includ-
ing their prefrontal location [29]. The data suggested the
prefrontal cortex was a target anatomical region in exposed
children and its damage could have contributed to their
cognitive dysfunction. We next tested whether patterns of
brain growth, cognitive deficits, and WMH were associated
with exposures to MCMA air pollution [44]. Baseline and
1-year followup measurements of global and regional brain
MRI volumes, cognitive abilities (Wechsler Intelligence Scale
for Children-Revised, WISC-R), and serum inflammatory
mediators were collected in 20 MCMA children (10 with
white matter hyperintensities, WMH (+), and 10 without,
WMH (−)) and 10 matched controls (CTL). There were
significant differences in white matter volumes between CTL
and MCMA children—both WMH (+) and WMH (−)—in
right parietal and bilateral temporal areas. Both WMH (−)
and WMH (+) MC children showed progressive deficits,
compared to CTL children, on the WISC-R Vocabulary and
Digit Span subtests. Interestingly, the cognitive deficits in
MCMA children matched the localization of the volumetric
differences detected over the 1 year followup [44].
When we analyzed the WMH lesions in relation to the
profile of cytokines and chemokines [32], MCMAWMH (−)
children displayed the profile of classical proinflammatory
defensive responses: high interleukin 12, production of pow-
erful proinflammatory cytokines, and low concentrations of
key cytokines and chemokines associated with neuroprotec-
tion. In contrast,MCWMH(+) children exhibited a response
involved in resolution of inflammation, immunoregulation,
and tissue remodeling. The MC WMH (+) group responded
to the air pollution-associated brain volumetric alterations
with white and grey matter volume increases in temporal,
parietal, and frontal regions and better cognitive performance
compared to MCWMH (−).
These findings suggest a complex modulation of cy-
tokines and chemokines influencing children’s white mat-
ter hyperintensities, volumetric white matter responses and
cognitive outcomes as a result of environmental pollution
exposures.
3. Neuroinflammation and Neuropathology in
Mexico City Children and Young Adults and
Comparative Studies
In 2002, we published a dog study pointing to the nasal
cavity as a major portal of entry of xenobiotics to the brain
[45]. The study evaluated 32 healthy mongrel MCMA dogs,
versus 8 dogs from Tlaxcala, a low polluted control city.
MCMA dogs exhibited expression of nuclear neuronal NF-
kappa B and iNOS in cortical endothelial cells at ages 2
and 4 weeks with subsequent damage to the blood-brain
barrier (BBB), deposition of Apolipoprotein E (APOE)-
positive lipid droplets in smooth muscle cells and pericytes,
diffuse amyloid plaques, and neurofibrillary tangles [45].
Nasal respiratory and olfactory epitheliumwere clearly found
to be early pollutant targets, as evidenced by the significant
apurinic/apyrimidinic (AP) sites in MCMA dogs versus
controls [46]. Moreover, olfactory bulb and hippocampal AP
sites were also significantly higher in MCMA animals and
nickel (Ni) and vanadium (V) were present in a gradient
from olfactory mucosa > olfactory bulb > frontal cortex [46].
Striking findings in our canine studies included the presence
of diffuse amyloid plaques in 11-month-old dogs and the
presence of oil combustion PM-associated metals Ni and V
in brain target areas. The dog studies are critical as they
showed Alzheimer pathology beginning early in life with air
pollutants playing a crucial role. Healthy young dogs exhibit a
striking acceleration of Alzheimer’s pathology when they live
in a highly polluted place. It is well known that dogs are a good
aging model and AD-type pathology and cognitive deficits
are seen in older animals [47–49].
3.1. Neuroinflammation and Vascular Damage in MCMA
Children and Young Adults. A very critical component of air
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pollution exposure is neuroinflammation [8, 50–52]. MCMA
young urbanites exhibit an important frontal imbalance
in genes essential for inflammation, innate and adaptive
immune responses, oxidative stress, cell proliferation and
apoptosis, when compared to age-matched residents in low
pollution cities [30]. Measurements of mRNA cyclooxygen-
ase-2, interleukin-1beta, and CD14 in target brain regions
from 12 controls and 35 MC residents aged 25.1 ± 1.5
years showed upregulation of cyclooxygenase-2, IL-1𝛽, and
CD14 in supra, and infratentorial regions and cranial nerves
including: olfactory bulb, frontal cortex, substantia nigrae,
and the vagus nerve [35].
The entry of activated lymphocytes, mast cells, and
macrophages into the brain parenchyma is a hallmark of
chronic inflammatory processes [34, 53–56]. Clusters of
mononuclear cells around blood vessels and activated mi-
croglia in the frontal and temporal cortex, subicular area,
and the brain stem (Figure 3(a)) were present in all MCMA
children and were extremely rare in control children [30,
35]. These mononuclear cells are positive for CD68, CD163,
Iba-1 (Figure 3(a)), and HLA-DR (Figure 3(b)) [57]. Intact
and degranulated mast cells identified by means of tryptase
monoclonal antibodies are seen in perivascular locations in
frontal (Figure 3(c)) and temporal cortices, as well in trigem-
inal ganglia, and in peripheral autonomic nerves innervat-
ing the lungs and hearts in MCMA subjects, whereas in
the controls mast cells were rare and intact. Blood vessels
exhibit vacuolated endothelial cells andmarginalWBCs, both
indicative of endothelial damage and activation (Figure 3(d)).
While the presence of abundant lipofuscin in endothelial cells
(Figure 3(e))—usually associated with aging and indicative
of a highly oxidized and covalently cross-linked aggregate of
proteins—is evidence of a dysfunctional lysosomal degrada-
tion not expected in children or young adults.
Therewas extensive vascular damage in the olfactory bulb
and in the frontal cortex. In the prefrontal cortex, the vascular
damage affects predominantly whitematter (Figure 3(f)).The
main vascular findings included thickened walls, abundant
perivascular macrophages, and focal enlargement of the
Virchow-Robin spaces (Figure 3(g)). Young dogs show simi-
lar lesions to children with significant endothelial cell hyper-
plasia markedly reducing the vessel lumen (Figure 3(h)).
The extensive prefrontal vascular damage is accompanied by
whitematter focal damage that in some children is significant
(Figure 3(i)). Extensive leaking of blood vessels involves
supra and infratentorial regions (Figures 3(j) and 3(k)).
Olfactory bulb arterioles also show marked focal thickening
of the vessel walls, indicative of a chronic reparative process
(Figure 3(l)).
Ultrafine particles are likely players in the endothelial cell
activation and are found in various CNS regions, including
the Olfactory bulb (Figure 3(m)). UFPM are also seen in
erythrocytes with the formation of patterned discrete contact
points between endothelial cells and RBCs in the CNS,
trigeminal ganglia, and lung capillaries of highly exposed
people [35].
3.2. Alzheimer’s and Parkinson’s Diseases Hallmarks. A grow-
ing body of epidemiologic and experimental data point
to particulate matter components of air pollution as well
as nanoparticles in the environment as risk factors for
neurodegenerative diseases [51, 52, 58–63]. Indeed, exposure
to different size and composition PM produce molecular
hallmarks of neurodegeneration, including the production
and deposit of misfolded protein aggregates (amyloid, alpha
synuclein, hyperphosphorylated tau), oxidative stress, cell
damage and death in susceptible neuronal populations [51, 52,
64–66]. Neuronal oxidative stress is prominent even in small
MCMAchildren [35]. Extensive cytoplasmic accumulation of
8OHdG in key neuronal complexes (Figure 4(a)) correlates
with oxidative stress and damage to DNA. Nitrotyrosine, a
marker for inflammation and nitric oxide (NO) production,
is also present in frontal neurons and infratentorial neu-
ronal groups (Figure 4(b)). Nitrotyrosine positive inclusions
are also seen in glial cells, microglia, and perivascular
macrophages [35].
3.2.1. Cortical Neurodegeneration Hallmarks. In young
MCMA residents, amyloid beta42 (A𝛽42) frontal
(Figure 4(c)), olfactory bulb, and/or hippocampal immuno-
reactivity was observed in 58.8% ofApolipoprotein E (APOE)
3/3 <25 y, and 100% of the APOE 4 subjects (Figure 4(d)),
whereas 𝛼-synuclein was seen in 23.5% of <25 y subjects
[29]. In a different MCMA cohort, aged 18.3 ± 6.9 years, 40%
exhibited tau hyperphosphorylation with pretangle material
(Figures 4(e) and 4(f)) and 51% had A𝛽42 diffuse frontal
plaques compared with 0% in controls [30]. Thus, diffuse
amyloid plaques and pretangle hyperphosphorilated tau are
common frontal findings in highly exposed children, while
low pollution controls are negative.
3.2.2. Brainstem Neurodegeneration Hallmarks. Infratento-
rial involvement is also present in exposed children thus
neuropathology is seen in the brainstems of children age
96.3 ± 8.5 months from highly polluted (𝑛 = 34) versus a
low polluted city (𝑛 = 17) [67]. Figure 5(a) shows medial
superior olivary neurons with strong oxidative stress as evi-
denced by their 8-hydroxyguanosine immunoreactivity. MC
children have auditory and vestibular abnormal findings [67].
The pathology involves every level of the brainstem from
the midbrain to the lower medulla. The substantia nigrae
pars compacta displays IBA-1 microglia. The number of
activated microglia also varies significantly between control
and MCMA children (Figures 5(b) and 5(c)). Activated
microglia are found throughout the brainstem in exposed
children (Figures 5(c), 5(d), and 5(e)), along with reactive
glial fibrillary acidic protein (GFAP) positive astrocytes,
indicative of responsive glia to cell damage (Figure 5(f)).
Accumulation of𝛼-synuclein, activatedmicroglia, extracellu-
lar neuromelanin, and pigment-laden macrophages are seen
from the dorsal motor nucleus of the vagus level (Figure 5(g))
to the substantia nigrae midbrain sections (Figures 5(h) and
5(i)). There is a punctuated cytoplasmic accumulation of 𝛼-
synuclein in affected neurons, while 𝛼-syn positive neurites
are also seen in the neuropil.
3.2.3. Olfactory Bulb Neurodegeneration. The olfactory bulb
pathology deserves special attention because large segments
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(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k) (l) (m)
Figure 3: (a) Eleven year old MCMA girl with abundant ionized calcium binding adaptor molecule 1 (Iba-1)-positive microglia.
Approximately 50% of the perivascular cells are Iba-1+ (Iba-1 antibody with DAB + brown product). (b) Eleven year old MCMA girl with
brainstemperivascular accumulation ofHLA-DRpositive cells (HLA-DR antibody andDAB+brownproduct). (c) Frontal cortex in aMCMA
24 y old male with perivascular partially degranulated tryptase positive cells (Tryptase Ab with DAB + brown product). (d) Olfactory bulb
blood vessel in a 14 year old MCMA boy. Notice a vacuolated endothelial cell and a polymorphonuclear leucocyte (PMN) attached to the
vessel wall. Two glomeruli are adjacent to the damaged vessel. H&E. (e) Olfactory bulb blood vessel in a 14-year-old MCMA male APOE
3/3. Endothelial cells in the delicate vessel exhibit abundant lipofuscin, a highly oxidized and covalently cross-linked aggregate of proteins
associatedwith aging. H&E. (f) Frontal cortexwhitematter from aMCMA33 year old healthy subject with a cluster of blood vessels displaying
perivascular numerous macrophages with lisosomal bodies and lipofuscin. The larger vessel displays abundant cell debris within the wall.
One micron toluidine blue section. (g) Fourteen year old MCMA girl prefrontal white matter with an abnormal blood vessel displaying
perivascular macrophages with lisosomal bodies and lipofuscin, abundant cell debri within the wall, apoptotic nuclei and focal enlargement
of the Virchow-Robin space. One micron toluidine blue section. (h) Vascular lesions are also seen in young MCMA dogs. This 19 month dog
exhibits a frontal white matter arteriole with hyperplastic endothelial cells partially reducing the lumen. One micron toluidine blue section.
(i)The prefrontal cortex exhibits extensive vascular white matter damage, illustrated in this 13 y oldMCMA girl.The arteriole shows extensive
perivascular accumulation of macrophages with abundant lisosomal bodies. A striking enlargement of the Virchow-Robin space is seen with
focal white matter damage. One micron toluidine blue section. (j) Seventeen year old MCMA teen brainstem blood vessel with extensive
leaking expanding the Virchow-Robin space. (k) Same child as (j), the breakdown of the neurovascular unit also affects smaller blood vessels.
(l) Electron micrograph of an olfactory bulb arteriole in a 17 y old MCMA boy.There is marked focal thickening of the vessel wall, numerous
perivascular macrophages with lisosomal bodies and lipofuscin and vacuolization of endothelial cells. (m) Nanosized particles are seen in
endothelial cells in many brain regions. This electron micrograph from a 17 y old MCMA male shows an arteriole in the olfactory bulb with
two sharply defined particles in the endothelial cell cytoplasm and its basementmembrane.Theparticles are 16 to 20 nanometers. EM×50,000.
of the world population are exposed to a myriad of toxic
substances on a daily basis that have the potential for
harming the olfactory system and penetrating the brain via
the olfactory epithelium (OE) [68–71]. Extreme instances of
such exposures in the USA include the massive dust cloud
following the September 11, 2001, terrorist attack in New
York City, smoke and debris from wildfires, exposures to
airborne herbicides and pesticides in farming communities,
and pollutants from vehicle exhaust and manufacturing
enterprises in major metropolitan areas. The issue is very
important because olfactory dysfunction is among the earliest
“preclinical” features of AD and PD, occurring in ∼90% of
early onset cases [72–76].
In MCMA residents, the severe pathological changes in
the nasal respiratory epithelium go hand and hand with a
marked decrease in olfactory neurons, significant changes in
Bowman’s glands, and pathologic Alzheimer and Parkinson’s
early stage changes within the olfactory bulbs (OBs) [77].
In one study comparing the OBs of 35 young MCMA
residents versus 9 controls (20.8±8.5 years) from aminimally
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(a) (b) (c)
(d) (e) (f)
Figure 4: (a) Eleven yearMCMAgirl dorsalmotor nucleus of the vagus stainedwith anti-8-OHdG showing immunohistochemical staining of
oxidized nucleoside in neurons. 8-hydroxyguanosine is amodified base that occurs in DNA due to attack by hydroxyl radicals that are formed
as byproducts and intermediates of aerobic metabolism and during oxidative stress. 8-OHdG immunohistochemistry red product. (b) Same
11 y old girl as in Figure 4(a) showing caudal pontine reticular nucleus neuronal protein oxidationmarked by nitrotyrosine immunoreactivity.
(c) Frontal cortex in an APOE 3/3 17 y old MCMA teen. A diffuse amyloid plaque (red product) is seen surrounded by glial cells negative
for reactive astrocytes as detected by their reaction to the glial fibrillary acidic protein (GFAP). Dual immunohistochemistry for amyloid
beta 1–42 and GFAP (DAB + brown product). (d) Frontal cortex in a 36 y old MCMAmale APOE 3/4. This subject shows numerous diffuse
and mature amyloid beta 1–42 plaques. (e) Frontal cortex in a 15 y old MCMA APOE 3/3 boy. Abnormal tau protein positive with the Tau 8
antibody (Innogenetics, Belgium), both in the neuronal body and in neuritis. (f) Frontal cortex in a 15 y old MCMA APOE 3/4 boy. A clear
Tau 8 positive neurite is seen.
polluted city, the MC residents exhibited significant amounts
of particles in OB glomerular neurons (Figure 6(a)), while
reactive astrocytes were prominent in young children
(Figure 6(b)). Immunoreactivity to alpha-synuclein, a hall-
mark of Parkinson’s disease was present in OB neurons of
MCMA teens and young adult (Figures 6(c), 6(d), and 6(e))
[77]. While neuronal accumulation of A𝛽42 was present in
young children regardless of APOE genotype (Figure 6(f)).
Thebasic laminarOBorganization of the glomerular, external
plexiform, mitral cell, internal plexiform, and granular cell
layers of the controls were generally intact (Figure 6(g)).
In contrast, ill-defined and fragmented organization of the
olfactory bulb layers, including small acellular glomeruli
characterized MCMA youngsters (Figure 6(h)). The changes
were extreme in APOE 4 carriers (Figures 6(i) and 6(j)).
The early olfactory deficits appear to be associated with the
aforementioned presence of beta amyloid, alpha synuclein,
particulate matter in glomerular structures and the massive
distortion of the OB organization.
3.3. The Role of the APOE Genotype in the Brain Effects
of Air Pollution. The Apolipoprotein E (APOE) 4 polymor-
phism influences aging and age-related diseases including
the risk for Alzheimer’s disease [78–80]. The differential
effects of ApoE isoforms on AD risk are given at least in
part by the ability to affect A𝛽 aggregation and clearance
in the brain, effects on synaptic plasticity, cell signaling,
lipid transport andmetabolism, and neuroinflammation [78].
APOE receptors influence both the CNS effects of APOE as
well as A𝛽 metabolism and toxicity. The APOE 4 genotype
(in contrast to APOE 3) is associated with oxidative stress
and chronic inflammation [78]. In traumatic brain injury,
APOE 4 carriers may be more predisposed to brain cellular
damage as measured by S-100B and NSE concentrations [79].
APOE4 also influences plasma lipid concentrations, increases
the risk of type 2 diabetes mellitus (particularly among
obese subjects and smokers), conditions associated with
high oxidative stress, neuroinflammation, and brain vascular
damage [80]. In keepingwith the current literature suggesting
APOE 4 carriers have disadvantages in terms of brain repair,
management of A𝛽 metabolism and toxicity and increased
oxidative stress and chronic inflammation, we have shown
MCMA APOE4 carriers have greater hyperphosphorylated
tau and diffuse A𝛽 plaques versus E3 carriers (𝑄 = 7.82,
𝑃 = 0.005) [30]. This observation is important because based
on our data, air pollution moderates the association between
APOE genotype and neurodegenerative changes, that is, an
APOE4 carrier residing in a highly polluted environmentwill
have an acceleration of neurodegenerative changes towards
AD [35]. This information is critical when planning the
neuroprotection of susceptible populations exposed to air
pollutant components.
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Figure 5: (a) Medial superior olive neurons from an 11 year old MCMA girl exhibit strong positivity for 8-hydroxyguanosine indicative of
oxidative stress. 8-OHdG immunohistochemistry DAB brown product. (b) Substantia nigrae, pars compacta in a 17 y old Control teen. The
section has been stained for the ionized calcium binding adaptor molecule 1 (IBA-1). There are very few positive cells. IBA-1 antibody with
red product. (c) In contrast, this is the substantia nigrae, pars compacta in a 14 y old MCMA teen stained for IBA-1. Numerous positive cells
are seen among the pigmented neurons and in perivascular locations. IBA-1 antibody with red product. (d) The same child has numerous
positive IBA-1 activated microglia in her vestibular nuclei. IBA-1 antibody with brown product. (e) Same child as previous picture. Positive
IBA-1 activated microglia in her dorsal motor nucleus of the vagus. IBA-1 antibody with brown product. (f) Reactive astrocytes are part of
the response of glial cells to cell damage. Reactive astrocytes positive for GFAP surround the dorsal motor nucleus of the vagus neurons
in this MCMA teen. GFAP with DAB brown product. (f) The dorsal motor nucleus of the vagus displays positive 𝛼 synuclein neurons in
the same child as 5F. 𝛼-Synuclein with red product. (h) The substantia nigrae is an early target in highly exposed teens. In this 11 y old girl
there are partially degranulated pigmented neurons with a few macrophages containing the pigmented granules. An elongated microglia-
like cell contains such brown granules in the vicinity of a neuronal shadow. H&E. (i) Substantia nigrae pigmented neuron is positive for
alpha-synuclein in this 14 y old MCMA girl. 𝛼-Synuclein with red product.
4. Compensatory Responses versus
Neurotoxic and Neurodegenerative
Changes. Friend or Foe?
In our pediatric studies, the early clinical olfactory deficits
appear to be associated with the presence of misfolded
proteins, reactive gliosis and vascular damage in the olfactory
bulb and the frontal cortex [77]. There is no doubt the
extensive olfactory bulb pathology likely affects OB proteins
with critical functions [81]. Likewise, the prefrontal cortex
differential regulation of key gene networks; that is, IL1,
NF𝜅B, TNF, IFN, andTLRs are likely players in the significant
cognitive deficits observed in children with no risk factors for
neurological or cognitive deficits, other than their residency
in a highly polluted megacity [29, 32, 33, 77]. In the same
stream of thought, the central delay in the brainstem auditory
evoked potentials and the significant whitematter volumetric
changes described after 1-year followup of MCMA versus
control children could be related to the accumulation of
abnormal proteins in key neuronal groups and the significant
neuroinflammation involving both gray and white matter
[30, 35, 67].
In view of the cognitive, olfactory, auditory, vestibular,
and volumetric white matter changes described in exposed
children, a series of critical questions arise:
(1) What is the role of PM in the neuroinflammatory
process described in highly exposed children?
(2) What is the relationship between clinical and electro-
physiological changes and the described neuropathol-
ogy?
(3) How to interpret the neuropathology hallmarks of
AD and PD in a 10 year old child with no family
history of neurological diseases?
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Figure 6: (a) Fourteen year oldMCMAboy with abundant particulate material in neurons in the glomerular region.The insert shows a close-
up of one such neuron with abundant particles and positive red cytoplasmic stain for A𝛽42. A𝛽42 immunohistochemistry and hematoxilin
counterstain. (b) Reactive astrocytes are seen in the olfactory bulbs of MC children and teens. This is a 14 y old MCMA boy with reactive
olfactory bulb astrocytes strongly staining for GFAP. GFAP immunohistochemistry with red product. (c) Olfactory bulb in an 11 y oldMCMA
boyAPOE 3/3. Numerous neurons display positive cytoplasmic granular staining.𝛼-Synucleinwith red product. (d) A close-up of an olfactory
bulb neuron with abundant 𝛼-Synuclein. (e) A close-up of a Lewy neurite is seen. 𝛼-Synuclein with red product. (f) Eleven year old MCMA
male with 𝛽-amyloid 1–42 in olfactory bulb neurons. A𝛽42 immunohistochemistry and hematoxilin counterstain. (g) This is the olfactory
bulb of a control 20 year old male from a low polluted city. The glomerular structures are organized and exhibit normal cellular components.
H&E. (h) In contrast, this is the olfactory bulb of an 11 year old MC boy APOE 3/3 with abnormal, loose and low cellular glomeruli. H&E.
(i) Even more striking changes are seen in this 32 y old MC APOE 4/4 female. There are no remaining normal glomeruli, the few structures
remaining are ill-defined with very few cells o no cells at all. It is expected this individual had significant olfactory deficits. H&E. (j) Same case
as (i).Theolfactory bulb shows extensive premature accumulation of corporae amylacea: glycoproteinaceous inclusions in astrocytic processes
associated with astrocytic injury and gliosis. Premature accumulation of corpora amylacea plays an important role in the sequestration of
toxic cellular metabolites. H&E.
Let us begin with the issue of particulate matter: Mexico
City residents have been chronically exposed to concentra-
tions of particulate matter above the USA standards for the
last 26 years [1, 12, 13, 16]. A considerable fraction of the PM
2.5
consists of organic compounds including biologic compo-
nents from bacteria and fungi, and transition metals with
neurotoxic properties [17–19]. Environmental endotoxins—
from open field waste areas, waste water treatment plants,
open sewer channels, and daily outdoor deposits of 500 met-
ric tons of animal and human fecal material—are an impor-
tant part of the organic portion of PM
2.5
.
Why is PM important for MCMA children? Because fine
and ultrafine particles reach their brain by uptake through
olfactory neurons and cranial nerves, trafficking of macro-
phage-like cells loaded with PM from the lung capillary bed
to the systemic circulation, and by a direct transfer of ultrafine
particles from the systemic circulation and/or red blood cells
to brain endothelial cells [30, 35]. Our data and those of
others suggest that exposure to PM can activate pathogen
sensors, and that signaling by ROS can drive inflammatory
processes [82–86]. Asbestos and silica activate the NALP 3
inflammasome and NALP3 deficient mice have a significant
reduction of their lung inflammatory responses [41]. The
innate immune system rapidly detects invading pathogenic
microbes and eliminates them. We have shown an upregula-
tion of 27/84 frontal inflammasome associated genes, includ-
ing NOD-like receptors and proinflammatory caspases [30],
so it is biologically plausible that PMwith lipopolysaccharides
(PM-LPS) initiates an inflammatory brain response. Toll-
like receptors sense “extracellular microbes” (e.g., PM-LPS)
and trigger anti-pathogen signaling cascades [84]. Both LPS
responses and systemic inflammation are important for the
understanding of how the sensing of “microbial invaders”
could translate into signaling pathways that culminate in
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the transcriptional regulation of immune responsive genes
and how the activation of inflammasomes [84] could be a
contributing factor for CNS inflammatory responses. The
inflammasome activation results in caspase 1 activation lead-
ing to processing and secretion of proinflammatory cytokines
like IL1𝛽 to engage innate immune defenses [86]. Indeed, this
pathway is clearly active in MCMA children: the activation
of inflammasomes turns on the protease caspase-1. Caspase-
1 cleaves prointerleukin-1𝛽 into an active form. We have
repeatedly shown IL-1𝛽 in frontal cortex, olfactory bulb,
hippocampus, and the dorsal vagal complex is upregulated
in highly exposed children, dogs and mice compared to low
pollution controls [30, 35, 87]. There is a clear need for better
understanding of the role of inflammasome activation in
urban children’s brains and the defense against pathogens that
do not really exist (only components of them, e.g., PM-LPS),
and neuroinflammation. This is of particular importance as
neuroprotective strategies are being explored.
The relationship between clinical and electrophysiolog-
ical changes and the described neuropathology is of deep
interest to pediatricians working in polluted urban cen-
ters. We mentioned olfaction deficits and abnormal UPSIT
(University of Pennsylvania Smell Identification Test) scores
present in 35.5% of the MCMA teens versus 12% of age
matched controls [77]. Moreover, highly exposed APOE 4
carriers failed 2.4 ± 0.54 of the 10 UPSIT items identified in
one study as being most strongly related to AD [88], while
APOE 2/3 and 3/3 subjects failed only 1.36 ± 0.16 such items
(𝑃 = 0.01). The olfactory bulb neuropathology associated
with urban exposures is very similar to the one described in
early stages of AD and PD [89–96].
The central delayed brainstem auditory evoked potentials
(BAEPs), auditory impairment and vestibular dysfunction
could relate to the extensive brainstem inflammation with
accumulation of 𝛽 amyloid and alpha synuclein in key olfac-
tory nuclei [67]. Neurodegenerative changes in the dorsal
motor nucleus of the vagus, the nucleus of the solitary tract,
arcuate nucleus, raphe midline, and extra-raphe medial and
lateral tegmental neurons [67] are similar to the PD stages I
and II of Braak et al. [90, 91, 96].
It is difficult to establish the association between cognitive
deficits, frontal tau hyperphosphorylation, and amyloid-𝛽
diffuse plaques in the absence of cognitive and brainMRI data
in the demised children. However, we have shown a strong
relationship between residency, brain structural changes and
cognitive deficits [32]. MCMA children with WMH (+) are
responding to the air pollution exposures with white and grey
matter volume increases in temporal, parietal, and frontal
regions and better cognitive performance compared toWMH
negative children [32]. WMH in elderly people are associated
with clinical symptoms related to disruption of fiber tracts,
cognitive impairment risk, cerebral ischemia, neurodegen-
eration, cardiovascular, and metabolic diseases [97–106].
WMH partially identify underlying white matter pathol-
ogy and may be associated with widespread white matter
changes, the novel concept of white matter hyperintensities
penumbra [107]. Disruption of fiber tracts in the developing
brain could result in cortical cholinergic and monoamin-
ergic deafferentation and impact attention, emotion and
goal-directed behavior [99].The characterization ofWMH in
young urbanites is critical and knowledge about the complex
modulation of cytokines and chemokines in the setting of
air pollution are important because they may shed light
into the etiopathogenesis of well-characterized risk factors
for neurodegeneration, vascular, and cognitive disorders and
disability [106, 107].
A difficult question to answer is how to interpret the early
neuropathology hallmarks of Alzheimer’s and Parkinson’s
diseases in children with no family history of neurological
diseases.
In the Alzheimer’s brain, tau is abnormally hyperphos-
phorylated and it is aggregated into paired helical filaments
forming neurofibrillary tangles, a histopathological hallmark
of the disease [108]. Tau phosphorylation could be protective
(e.g., hibernation) or toxic (e.g., hyperphosphorylation and
aggregation of tau) [109]. Hyperphosphorylated tau in epi-
topes characteristic of AD has been identified by immunohis-
tochemistry in 62.5% of APOE 4 and 33% of APOE 3 young
MCMA carriers [30].
Is tau phosphorylation in children detrimental or pro-
tective in the setting of severe air pollution? [109–114]. The
aggregation of HP tau species has been proposed to represent
a compensatory neuronal response against oxidative stress
and to serve at least initially as a protector against cell death
[111, 113].The tau protective or toxic function could be related
to different conformational molecular changes [109]. The
formation of tangles is a quick process as it was demonstrated
by De Calignon et al. [112] using in vivomultiphoton imaging
in living tau transgenic mice. Caspase activation precedes
tangle formation by hours to days, tangles form quickly
but persist apparently indefinitely, thus cleavage of tau is
enough to causemisfolding of tau followed by nucleation and
recruitment of additional tau molecules to the neuronal cell
body. Is our description of HP𝜏 in MCMA children’s brains
an isolated observation in the literature? The answer is no,
Braak and Del Tredeci [93] examined 42 young brains (4–29
years) with a wide range of pathologies described pretangle
HP𝜏 usingAT8 in 38/42 cases with no extracellular amyloid𝛽
protein deposition or neuritic plaques with the 4G8 antibody.
Although these subjects were not healthy, there was noAPOE
genotyping or a recordedhistory of environmental exposures,
we fully agree with Braak and Del Tredeci [93] that these
findings may indicate Alzheimer’s disease-related patholog-
ical process leading to neurofibrillary tangle formation start
quite early, before puberty or in early young adulthood.
There are very few arguments about the role of abnormal
tau hyperphosphorylation in AD, related tauopathies and
under experimental conditions [108, 109, 114–118]. A subject
to be explored in air pollution animal models ought to be
the characterization of the HP𝜏 and if indeed represents a
compensatory neuronal response against oxidative stress. At
this time, however, we are of the opinion that given the factors
(chronic oxidative stress, neuroinflammation, presence of
nanosize particles in critical brain units and anatomical
regions) potentially accounting for the aggregation of tau, tau
phosphorylation could represent an early sensor of oxidative
stress with all the subsequent detrimental effects if the expo-
sure persist.
BioMed Research International 11
Likewise, A𝛽42 is capable of aggregation and misfold-
ing leading to progressive neurodegeneration that develops
insidiously over a lifetime. A key issue has to be addressed
in this scenario: APOE4 carriers not only have HP𝜏, but also
exhibit significant numbers of A𝛽 6E10 diffuse plaques (𝑃 =
0.005) in comparison to APOE 3 carriers. Recent work by
Cerf et al. [119] suggests that APOE4 strongly stabilizes A𝛽
oligomers, the pathological species responsible for AD; thus
we suggest APOE4 carriers are potentially at a higher risk of
developing AD if residing in a highly polluted environment.
This information is critical given that ∼18% of the MCMA
population carries an APOE 4 allele [30].
Alpha-synuclein aggregation is associated to the patho-
genesis of Parkinson’s disease and exposure to a myriad of
environmental agents, including agrochemicals increases the
PD risk [120, 121]. Mitochondrial dysfunction and oxidative
stress constitute key PD pathogenic events. Alpha-synuclein
prevents cytochrome c release and apoptosis through inhi-
bition of the MAPK signaling pathway, suggesting that
endogenous concentrations of 𝛼-synuclein confer resistance
to oxidative stress downstream of free radical production and
scavenging [122]. Recent evidence also suggests misfolded 𝛼-
synuclein directly activates microglia inducing the produc-
tion and release of the proinflammatory cytokine, TNF-𝛼,
and increasing antioxidant enzyme expression [123]. Béraud
et al. emphasized the importance of protein misfolding,
oxidative stress, and inflammation in PD as a potential
locus for the development of novel therapeutics focused
on induction of the Nrf2-directed antioxidant pathway and
inhibition of protein misfolding [123].
It is important to note that 𝛼-synuclein in MCMA chil-
dren is present in key regions associated with PD pathology
including olfactory bulb, themidbrain, and the lower sections
of the brainstem, for example, themedulla oblongata [67, 77].
MCMA teens exhibit already olfactory disturbances [77] and
autonomic dysfunction (syncope in MCMA children per-
sonal communication of Dr. Maricela Franco-Lira), the latter
severe enough to require pediatric care. The issue of MCMA
children already showing symptoms seen in the premotor
stages of PD has to be well thoughtout [73, 74] given the
neurodegenerative process begins earlier in the olfactory bulb
and lower brain stem and the fact there is a delay of several
decades between the onset of dopaminergic denervation and
the appearance of motor signs [96]. There is no question
olfactory dysfunction is an early “preclinical” sign of Parkin-
son’s disease [73, 74]. Damage to cholinergic, serotonergic,
and noradrenergic components of the olfactory pathway
likely involved to explain the olfactory dysfunction [73,
74]. The presence of up-regulated inflammatory cytokines,
𝛼-synuclein- and HP𝜋-related olfactory bulb pathology in
young highly exposed children is an ominous sign possibly
associated with a number of other nonmotor symptoms
related to PD, such as dysautonomia and sleep disturbances.
Epidemiological studies addressing nonmotor PD symptoms
in highly exposed young urbanites are warranted.
4.1. Looking Forward and Limitations. Despite controver-
sy regarding the mechanistic pathways involved in the
CNS damage associated with exposure to air pollutants,
specifically fine and ultrafine particles of diverse origin, ani-
mal models and tissue culture studies have greatly improved
our understanding of the mechanistic processes [39, 41, 42,
48–52, 58–66, 69–71]. We are looking forward to bridg-
ing the gap between early neuroinflammation and neu-
rodegeneration observed in childhood and early adulthood
and experimental air pollution animal models. There is a
strong need for collaborations between those who investigate
humans and those who study experimental animal models
to derive therapies that may be neuroprotective. There is
also a need for looking into the neuropathology in diverse
populations residing in megacities across the globe and
sharing the results of the investigations. This is critical since
the responses to air pollutants depend not only on the
components of air pollution and concentrations, but also on
the genetic background of the exposed populations and on
a large list of environmental factors including dietary risk
factors, obesity, alcohol intake, and lifelong experiences for
example, educational and occupational attainment [124]. Our
results are potentially limited by the characteristics of the air
pollutants in MCMA and the populations we are studying,
namely ethnic groups with a complex admixture of ancestral
populations as seen with Mexican mestizos. Nevertheless,
the significant differences in clinical and neuropathology
findings between high and low pollution exposed subjects
warrants extensive investigations in exposed populations
from countries around the world.
5. Summary
MCMA children experience a chronic, intense state of oxida-
tive stress resulting from lifelong exposures to a severely
polluted environment. Children exhibit an early brain imbal-
ance in genes involved in oxidative stress, inflammation,
innate and adaptive immune responses, cell proliferation
and apoptosis. Neuroinflammation, endothelial activation,
endothelial cell hyperplasia, the attachment of white blood
cells to the endothelial damaged walls with the reduction of
the lumen vessel, high blood concentrations of endothelin-1,
and the breakdown of the BBB clearly contribute to cognitive
impairment and pathogenesis and pathophysiology of neu-
rodegenerative states [125, 126]. Environmental and genetic
factors play a key role in their CNS responses as evidenced
by the acceleration of neurodegenerative AD pathology in
children carrying an APOE 4 allele.
The neuronal accumulation of misfolded proteins in
exposed children coincides with the anatomical distribution
observed in the early stages of both AD and PD with early
clinical evidence of olfactory and cognitive deficits, brain vol-
umetric changes, white matter hyperintense lesions, altered
brainstem evoked auditory potentials and autonomic dis-
balance. There is a complex modulation of cytokines and
chemokines influencing structural and volumetric brain re-
sponses and cognitive deficits.
We contend that misfolding of critical proteins could
be a defensive early response to the sustained systemic and
CNS inflammation. However, the sustained oxidative stress
associated with dysregulated inflammation, both systemic
12 BioMed Research International
and in the CNS contribute to the establishment of neu-
rodegenerative processes with clinical early counterparts. We
strongly support the contention that the nasal (olfactory and
trigeminal), cardiorespiratory and gastrointestinal (vagus)
pathways-alongwith the systemic direct transport of particles
to the brain and the dysregulated systemic inflammation are
critical in explaining the brain pathology in highly exposed
MCMA children. Moreover, these children are at risk of
developing Alzheimer’s and Parkinson’s diseases as adults.
We have a 50-year window of opportunity between the
early brain changes observed in children and the time when
the patient with mild cognitive impairment or dementia will
showup at the neurologist’s door. Facing the current pediatric
clinical and pathology evidence is imperative if we are aiming
our efforts to identify andmitigate environmental factors that
influence AD and PD pathogenesis.
One thing is clear: early implementation of neuroprotec-
tive measures to ameliorate or stop the inflammatory and
neurodegenerative processes in children is warranted [43,
87]. Identification of biomarkers associating systemic inflam-
mation to brain growth is also critical for detecting children
at higher risk for cognitive deficits and neurodegeneration.
It is important to remember there is a severe and woeful
deficit of progress in the development of both AD and PD-
modifying therapy [127, 128]. Since fine and ultrafine PM
likely play a key role in the development of neuroinflamma-
tion and neurodegeneration, it is very noteworthy that in the
US alone, as of December 2012, more than 74 million people
are being exposed to concentrations of PM
2.5
above the 2006
standards (PM
2.5
annual standard of 15 𝜇g/m3) [129]. An
appeal to research supporting institutions may be made to
strongly invest in defining the CNS pathology associated with
exposure to air pollutants in children and young adults and
as Castellani and Perry suggested, consider a systems biology
approach and an early preventive pathway [128].
Epidemiological, cognitive, and mechanistic studies into
the association between air pollution exposures and the
development of CNS damage in children are of pressing
importance for public health and quality of life.
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[22] E. Fröhlich and E. Roblegg, “Models for oral uptake of nanopar-
ticles in consumer products,” Toxicology, vol. 291, no. 1–3, pp.
10–17, 2012.
[23] R. W. Atkinson, I. M. Carey, A. J. Kent, T. P. van Staa, H. R.
Anderson, and D. G. Cook, “Long-term exposure to outdoor
air pollution and incidence of cardiovascular disease,” Epidemi-
ology, vol. 24, pp. 44–53, 2013.
[24] Z. F. Zhang, S. Z. Yu, and G. D. Zhou, “Indoor air pollution
of coal fumes as a risk factor of stroke, Shanghai,” American
Journal of Public Health, vol. 78, no. 8, pp. 975–977, 1988.
[25] P. J. Villeneuve, J. Y. Johnson, D. Pasichnvk, J. Lowes, S.
Kirkland, and B. H. Rowe, “Short-term effects of ambient air
pollution on stroke: who is most vulnerable?” Science of the
Total Environment, vol. 430, pp. 193–201, 2012.
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[46] L. Calderón-Garcidueñas, R. R. Maronpot, R. Torres-Jardon,
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